Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Gene expression profiling and genetic markers in glioblastoma survival.

Rich JN, Hans C, Jones B, Iversen ES, McLendon RE, Rasheed BK, Dobra A, Dressman HK, Bigner DD, Nevins JR, West M.

Cancer Res. 2005 May 15;65(10):4051-8.

2.

Primary and secondary glioblastomas: from concept to clinical diagnosis.

Kleihues P, Ohgaki H.

Neuro Oncol. 1999 Jan;1(1):44-51. Review.

3.

Correlation of molecular genetic analysis of p53, MDM2, p16, PTEN, and EGFR and survival of patients with anaplastic astrocytoma and glioblastoma.

Ushio Y, Tada K, Shiraishi S, Kamiryo T, Shinojima N, Kochi M, Saya H.

Front Biosci. 2003 May 1;8:e281-8. Review.

PMID:
12700122
4.

Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression.

Nozaki M, Tada M, Kobayashi H, Zhang CL, Sawamura Y, Abe H, Ishii N, Van Meir EG.

Neuro Oncol. 1999 Apr;1(2):124-37. Review.

5.
6.

Brain tumours: classification and genes.

Collins VP.

J Neurol Neurosurg Psychiatry. 2004 Jun;75 Suppl 2:ii2-11. Review. No abstract available.

7.

PTEN signaling pathways in glioblastoma.

Koul D.

Cancer Biol Ther. 2008 Sep;7(9):1321-5. Epub 2008 Sep 8. Review.

PMID:
18836294
8.

Genetic markers in glioblastoma: prognostic significance and future therapeutic implications.

Hill C, Hunter SB, Brat DJ.

Adv Anat Pathol. 2003 Jul;10(4):212-7. Review.

PMID:
12826827
9.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
10.

[Genes implicated in glial tumors].

Sanson M, Marie Y, Huguet S, He J, Hoang-Xuan K.

Morphologie. 2000 Jun;84(265):51-5. Review. French.

PMID:
11048299
11.

Molecular profiling in glioblastoma: prelude to personalized treatment.

Mladkova N, Chakravarti A.

Curr Oncol Rep. 2009 Jan;11(1):53-61. Review.

PMID:
19080742
12.

Molecular abnormalities and correlations with tumor response and outcome in glioma patients.

Pollack IF, Hamilton RL, Finkelstein SD, Lieberman F.

Neuroimaging Clin N Am. 2002 Nov;12(4):627-39. Review.

PMID:
12687916
13.

Tumor suppressor genes in lung cancer.

Virmani AK, Gazdar AF.

Methods Mol Biol. 2003;222:97-115. Review. No abstract available.

PMID:
12710682
14.

Genetic pathways to glioblastomas.

Ohgaki H.

Neuropathology. 2005 Mar;25(1):1-7. Review.

PMID:
15822813
15.

Molecular analysis of glioblastoma: pathway profiling and its implications for patient therapy.

Mischel PS, Nelson SF, Cloughesy TF.

Cancer Biol Ther. 2003 May-Jun;2(3):242-7. Review.

PMID:
12878856
16.

Molecular diagnostic techniques for the clinical evaluation of gliomas.

Kelley TW, Tubbs RR, Prayson RA.

Diagn Mol Pathol. 2005 Mar;14(1):1-8. Review.

PMID:
15714057
17.

Molecular genetic analysis of deep-seated glioblastomas.

Hayashi Y, Yamashita J, Watanabe T.

Cancer Genet Cytogenet. 2004 Aug;153(1):64-8. Review.

PMID:
15325097
18.

[Abnormalities of the EGF receptor gene in brain tumors].

Shibuya M.

No To Shinkei. 1998 Jun;50(6):519-27. Review. Japanese. No abstract available.

PMID:
9656247
19.

Prognosis-related molecular markers in pediatric central nervous system tumors.

Rickert CH.

J Neuropathol Exp Neurol. 2004 Dec;63(12):1211-24. Review.

20.

[System biological approach to research and treatment of brain tumors].

Shiraishi T, Tabuchi K, Kotani S, Konagaya A.

Tanpakushitsu Kakusan Koso. 2003 Jun;48(7):795-801. Review. Japanese. No abstract available.

PMID:
12795192
Items per page

Supplemental Content

Write to the Help Desk